Wan Yi-Gang, Sun Wei, Wang Yang
Department of Traditional Chinese Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Dec;26(12):1094-102.
To examine the effect of multi-glycoside of Tripterygium wilfordii Hook. f. (GTW) on proteinuria and expression of slit diaphragm-associated molecules such as nephrin and podocin in glomerulonephritis induced by anti-Thy1.1 antibody (anti-Thy1 . 1 GN).
Anti-Thy1.1 GN was induced in rats by a single intravenous injection with 500 microg of anti-Thy1.1 mAb 1-22-3. Fourteen rats were randomly divided into 2 groups, the GTW-treated group and vehicle treated group, and sacrificed on day 14 in Experiment 1 or on day 7 in Experiment 2 after induction of Anti-Thy1.1 GN. Daily oral administration of GTW and vehicle as a control was started from 3 days before injection or at the same time of injection to the day of sacrifice in Experiment 1 or 2. Proteinuria was determined during 14 days in Experiment 1 or during 7 days in Experiment 2. From kidneys taken at sacrifice, glomerular morphological changes, glomerular macrophage infiltration, glomerular expression of nephrin and podocin, and its mRNA expression in renal tissue were examined.
In Experiment 1, proteinuria and mesangial matrix expansion were significantly attenuated by GTW treatment. No difference in staining intensity of nephrin and podocin in glomeruli was observed between GTW treated group and vehicle treated group on day 14. In Experiment 2, GTW treatment significantly ameliorated proteinuria, mesangial injury and activated macrophage infiltration in glomerulus. In addition, it significantly increased the expression of nephrin and podocin and its mRNA expression in glomeruli on day 7.
In anti-Thy1.1 GN, the reduced expression of nephrin and podocin may contribute to the development of mesangial injury and proteinuria. The findings suggest that GTW ameliorates not only proteinuria but also mesangial lesions in anti-Thy1 . 1 GN most likely by increasing the expression of nephrin and podocin.
研究雷公藤多苷(GTW)对抗Thy1.1抗体诱导的肾小球肾炎(抗Thy1.1 GN)蛋白尿及裂孔隔膜相关分子如nephrin和podocin表达的影响。
通过单次静脉注射500μg抗Thy1.1单克隆抗体1-22-3诱导大鼠抗Thy1.1 GN。14只大鼠随机分为2组,即GTW治疗组和溶剂对照组,在诱导抗Thy1.1 GN后的实验1第14天或实验2第7天处死。在实验1或2中,从注射前3天或注射同时开始每日口服GTW和作为对照的溶剂,直至处死当天。在实验1的14天或实验2的7天内测定蛋白尿。处死时取肾脏,检查肾小球形态变化、肾小球巨噬细胞浸润、肾小球nephrin和podocin表达及其在肾组织中的mRNA表达。
在实验1中,GTW治疗显著减轻蛋白尿和系膜基质扩张。在第14天,GTW治疗组和溶剂对照组肾小球中nephrin和podocin的染色强度无差异。在实验2中,GTW治疗显著改善蛋白尿、系膜损伤和肾小球中活化巨噬细胞浸润。此外,在第7天,它显著增加肾小球中nephrin和podocin的表达及其mRNA表达。
在抗Thy1.1 GN中,nephrin和podocin表达降低可能导致系膜损伤和蛋白尿的发生。研究结果表明,GTW改善抗Thy1.1 GN中的蛋白尿和系膜病变,很可能是通过增加nephrin和podocin的表达实现的。